Takahashi et al. studied the effects of trodusquemine in genetically leptin-deficient Lepob/ob mice, a well-known mammalian model of severe insulin resistance, obesity, and hepatic steatosis [87]. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.